Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 59 for “"Leukemic stem cells"”.

  1. Immunotherapy of Leukemic Stem Cells using Natural Killer Cell Lines

    … has focused on the interaction of bulk tumour cells with the immune system. The discovery of stem cells in a number of cancers including leukemia has raised new questions about the how the immune system interacts with these cancer stem cells and has implications for immune based therapies. Here …

    toronto-retro Repository record for Immunotherapy of Leukemic Stem Cells using Natural Killer Cell Lines (opens in a new tab)

  2. Characterising the cell biology of leukemic stem cells in acute myeloid leukemia.

    … be due to the presence of chemotherapy resistant leukemic stem cells (LSC). Within the CD34+ disease (>5% of the blast cells expressing CD34) , two subtypes have been identified; an LMPP/GMPlike expanded type and a MPP/CMP-like expanded type, the former is the most common, accounting for around …

    oxford Repository record for Characterising the cell biology of leukemic stem cells in acute myeloid leukemia. (opens in a new tab)

  3. Investigating RNA-binding Protein Dependencies in Hematopoietic and Acute Myeloid Leukemic Stem Cells

    … through a delicate balance of hematopoietic stem cell (HSC) self-renewal versus differentiation. Leukemic stem cells (LSCs) arise from mutations in hematopoietic stem or progenitor cells and are both seeds of initiation as well as drivers of progression and relapse in acute myeloid leukemia …

    toronto-retro Repository record for Investigating RNA-binding Protein Dependencies in Hematopoietic and Acute Myeloid Leukemic Stem Cells (opens in a new tab)

  4. FLT3-directed antibody-drug conjugates to target leukemic stem cells in acute myeloid leukemia

    … patients that are ineligible for hematopoietic stem cell transplantation. While fast-proliferating blasts are eradicated by chemotherapy, quiescent and drug resistant leukemic stem cells (LSCs) persist and fuel disease re-occurrence. Fms-like receptor tyrosine kinase 3 (FLT3) is overexpressed on …

    lmu-germany Repository record for FLT3-directed antibody-drug conjugates to target leukemic stem cells in acute myeloid leukemia (opens in a new tab)

  5. EPIGENETIC ALTERATIONS INDUCED BY THE PML-RAR ONCOGENE DURING THE TRANSFORMATION PROCESS OF ITS TARGET CELLS

    … We found that PML-RARα can induce an adult stem cell signature in normal myeloid progenitors, distinct from that observed in frankly established leukemic stem cells. Among the transcriptional targets identified, the cell cycle inhibitor p21, required for self-renewal of normal and leukemic …

    milano Repository record for EPIGENETIC ALTERATIONS INDUCED BY THE PML-RAR ONCOGENE DURING THE TRANSFORMATION PROCESS OF ITS TARGET CELLS (opens in a new tab) Restricted access

  6. Kdm6b is Required for Self-Renewal of Normal and Leukemic Mouse Stem Cells Under Proliferative Stress

    … we examined the role of Kdm6b in hematopoietic stem cell (HSC) fate decisions under normal and malignant conditions to evaluate its potential as a therapeutic target. Loss of Kdm6b leads to a significant reduction in phenotypic and functional HSCs in adult mice, which increases with increased …

    wustl Repository record for Kdm6b is Required for Self-Renewal of Normal and Leukemic Mouse Stem Cells Under Proliferative Stress (opens in a new tab)

  7. Improved Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) of Affinity Maturated and Fc-Engineered Antibodies Directed Against the AML Stem Cell Antigen CD96

    … no long-term cure for about 70% of AML patients. Leukemic stem cells seem to be an important key for the perpetuation of AML.Most currently used chemotherapeutic agents are not able to eliminate AML-LSCs. The combination of conventional therapies with AML-LSCs-directed therapies may eventually …

    cau-kiel Repository record for Improved Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) of Affinity Maturated and Fc-Engineered Antibodies Directed Against the AML Stem Cell Antigen CD96 (opens in a new tab)

  8. Mechanism of STAT3 mediated Drug Persistence in Chronic Myeloid Leukemia Stem Cells

    … chronic myeloid leukemia (CML), a hematopoietic stem cell (HSC) disorder. HSCs acquire a single translocation between chromosome 9 and 22, forming BCR-ABL, a constitutively active tyrosine kinase. Tyrosine kinase inhibitors (TKI), the standard regimen, have been able to efficaciously control CML …

    uab Repository record for Mechanism of STAT3 mediated Drug Persistence in Chronic Myeloid Leukemia Stem Cells (opens in a new tab)

  9. Development of an Oral Drug Delivery System to Improve the Bioactivity of Avocatin B

    … capable of inducing apoptosis of leukemia and leukemic stem cells. Although this bioactive compound has demonstrated anti-leukemic activity in vitro, there is concern about its poor bioavailability. In this study, we exploited the surface-active properties of avocatin B to design …

    guelph Repository record for Development of an Oral Drug Delivery System to Improve the Bioactivity of Avocatin B (opens in a new tab)

  10. SRSF1-MEDIATED TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKAEMIA

    … BCR-ABL1-independent factors that preserve CML leukemic stem cells (LSCs). Using RNA-sequencing, we identified differentially expressed splicing factors in CD34+ CML stem and progenitor cells compared to healthy controls. Among them, we found SRSF1 to be consistently increased at both transcript …

    nus Repository record for SRSF1-MEDIATED TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKAEMIA (opens in a new tab) Download file for SRSF1-MEDIATED TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKAEMIA (opens in a new tab)

  11. NON-GENETIC MECHANISMS OF CHEMORESISTANCE IN ACUTE MYELOID LEUKEMIA

    … to the emergence of cellular resistance to anti- leukemic drugs. Drug resistance in leukemic cells has been associated with intratumoral heterogeneity, among which quiescence, specifically, is considered a key factor for cell survival. Experimental evidence collected both from patients and model …

    milano Repository record for NON-GENETIC MECHANISMS OF CHEMORESISTANCE IN ACUTE MYELOID LEUKEMIA (opens in a new tab)

  12. Exploring biological overlap between in vivo and in vitro stem and progenitor compartments in healthy hematopoiesis and acute myeloid leukemia

    Together, hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) oversee lifelong hematopoiesis. While HSC self-renewal and multilineage differentiation capacity are experimentally assayed through in vivo xenotransplantation assays, HPCs give rise to lineage restricted colonies …

    mcmaster Repository record for Exploring biological overlap between in vivo and in vitro stem and progenitor compartments in healthy hematopoiesis and acute myeloid leukemia (opens in a new tab)

  13. The GAB2/SHP2 Pathway in BCR-ABL1-Induced Hematopoietic Neoplasia

    … but CML patients suffer from persistence of leukemic stem cells (LSCs), and B-ALL patients exhibit poorer response at diagnosis compared with CML patients. Over time, such patients succumb to TKI-resistant leukemic clones. Therefore, additional therapeutic targets are needed to cure these …

    toronto-retro Repository record for The GAB2/SHP2 Pathway in BCR-ABL1-Induced Hematopoietic Neoplasia (opens in a new tab)

  14. Tracking clonal structure from leukemia diagnosis to relapse using mitochondrial variants

    … by clonal expansion of immature blood cells that leads to bone marrow failure. AML is a heterogeneous disease despite its low mutational burden, leading to a relapse rate of over 60\% within five years of diagnosis. Relapse is attributed to the persistence of leukemic stem cells which …

    ubc Repository record for Tracking clonal structure from leukemia diagnosis to relapse using mitochondrial variants (opens in a new tab) Download PDF for Tracking clonal structure from leukemia diagnosis to relapse using mitochondrial variants (opens in a new tab)

  15. Die Rolle des Hedgehog - Signalweges in der AML

    … was shown to be essential for the maintenance of leukemic stem cells in BCR-ABL+ myeloid leukemia, while regular hematopoietic stem cells are independent of HH-signaling. The aim of the presented study was to investigate the role of hedgehog signaling in AML.<br>Results: Immunohistochemistry …

    freiburg-diss Repository record for Die Rolle des Hedgehog - Signalweges in der AML (opens in a new tab)

  16. Targeting the antagonism of AHR by MSI2 as a novel anti-leukemic strategy in human acute myeloid leukemia

    … an aggressive malignancy of the hematopoietic system, characterized by the accumulation of abnormally differentiated blast cells that is driven by leukemic stem cells (LSCs). In murine AML, Musashi-2 (MSI2), an RNA-binding protein and positive regulator of stemness, has been implicated in the …

    mcmaster Repository record for Targeting the antagonism of AHR by MSI2 as a novel anti-leukemic strategy in human acute myeloid leukemia (opens in a new tab)

Page 1 of 3